Review
Mediastinal lymph node dissection for lung cancer. The Memorial experience
Affiliations
- PMID: 7613960
Item in Clipboard
Review
Mediastinal lymph node dissection for lung cancer. The Memorial experience
Chest Surg Clin N Am.
1995 May.
Abstract
A mediastinal lymph node dissection as opposed to lymph node sampling should be an integral part of the operation in all patients with resectable lung cancers. A systematic mediastinal node dissection affords the most accurate staging and a long-term survival in some patients when the positive regional nodes are also removed. It is safe and easy to do, adds only 20 to 30 minutes to the surgical procedure, and morbidity is minimal. Our reported survival data have been based on the routine use of mediastinal lymph node dissection in conjunction with pulmonary resection. Techniques of lymph node dissection for both right- and left-sided tumors are described along with a historical background of their evolution.
Similar articles
-
[Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].Ai Zheng. 2007 Mar;26(3):303-6. Ai Zheng. 2007. PMID: 17355796 Chinese.
-
Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.Ann Thorac Surg. 2005 Jul;80(1):268-74; discussion 274-5. doi: 10.1016/j.athoracsur.2005.02.005. Ann Thorac Surg. 2005. PMID: 15975380
-
Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.Eur J Cardiothorac Surg. 2007 Aug;32(2):356-61. doi: 10.1016/j.ejcts.2007.04.030. Epub 2007 May 21. Eur J Cardiothorac Surg. 2007. PMID: 17513118
-
[Radical surgery and lymph node dissection in bronchial carcinoma].Langenbecks Arch Chir Suppl Kongressbd. 1996;113:790-7. Langenbecks Arch Chir Suppl Kongressbd. 1996. PMID: 9101991 Review. German.
-
Surgical treatment of non-small cell lung cancer: mediastinal lymph node dissection.Rays. 2004 Oct-Dec;29(4):423-9. Rays. 2004. PMID: 15852730 Review.
Cited by
-
Non-small cell lung cancer staging: proposed revisions to the TNM system.Cancer Imaging. 2008 Sep 30;8(1):181-5. doi: 10.1102/1470-7330.2008.0029. Cancer Imaging. 2008. PMID: 18824424 Free PMC article. Review.
-
Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients.Ann Surg. 2006 Sep;244(3):420-5. doi: 10.1097/01.sla.0000234892.79056.63. Ann Surg. 2006. PMID: 16926568 Free PMC article.
-
Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer.BMC Cancer. 2019 May 14;19(1):444. doi: 10.1186/s12885-019-5632-2. BMC Cancer. 2019. PMID: 31088404 Free PMC article.
-
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.ESMO Open. 2023 Aug;8(4):101595. doi: 10.1016/j.esmoop.2023.101595. Epub 2023 Jul 11. ESMO Open. 2023. PMID: 37441877 Free PMC article.
-
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.ESMO Open. 2022 Apr;7(2):100455. doi: 10.1016/j.esmoop.2022.100455. Epub 2022 Apr 7. ESMO Open. 2022. PMID: 35398718 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical